Position in HIMS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Derivatives in HIMS
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$4,567,200
PutShares
220,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026683 Capital Management, LLC holds $21,267,000 across 1 Drug Manufacturers - Specialty & Generic name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
1,530,000 | $21,267,000 |
All Filings in HIMS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,567,200 | 220,000 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $11,039,800 | 340,000 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $17,583,200 | 310,000 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $15,453,500 | 310,000 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $4,432,500 | 150,000 | Put | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||